Yipeng Xu
Impact in
-
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Epigenetics and DNA Methylation 3
- DNA Repair Mechanisms 2
- Ubiquitin and proteasome pathways 2
-
- Prostate Cancer Treatment and Research 7
- Ferroptosis and cancer prognosis 2
- Co-authors
- Shaoxing Zhu (9 shared papers)Zongping Wang (6 shared papers)Cheng-Yi Liu (2 shared papers)Mei Song (3 shared papers)Michel Raymond (1 shared paper)Xu Yang (1 shared paper)Feng Cui (1 shared paper)Mylène Weill (1 shared paper)
In The Last Decade
Yipeng Xu
30 papers receiving 374 citations
Peers
Comparison fields: 5 of 72
- Cancer Research 47
- Oncology 60
- Molecular Biology 143
- Biochemistry 12
- Pulmonary and Respiratory Medicine 52
Countries citing papers authored by Yipeng Xu
This map shows the geographic impact of Yipeng Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yipeng Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yipeng Xu more than expected).
Fields of papers citing papers by Yipeng Xu
This network shows the impact of papers produced by Yipeng Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yipeng Xu. The network helps show where Yipeng Xu may publish in the future.
Co-authors
The 25 scholars most cited alongside Yipeng Xu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 43 | |
| 2 | 2006 | 34 | |
| 3 | 2016 | 34 | |
| 4 | 2019 | 29 | |
| 5 | 2022 | 24 | |
| 6 | 2014 | 22 | |
| 7 | 2023 | 22 | |
| 8 | 2021 | 20 | |
| 9 | 2022 | 17 | |
| 10 | 2014 | 17 | |
| 11 | 2016 | 15 | |
| 12 | 2022 | 11 | |
| 13 | 2022 | 11 | |
| 14 | 2019 | 11 | |
| 15 | 2023 | 9 | |
| 16 | Interleukin-16 rs4778889 polymorphism contributes to the development of renal cell cancer in a Chinese population. | 2015 | 9 |
| 17 | 2015 | 9 | |
| 18 | 2021 | 7 | |
| 19 | 2013 | 6 | |
| 20 | 2021 | 5 |
About Yipeng Xu
Yipeng Xu is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Surgery, Oncology and Endocrinology, Diabetes and Metabolism, having authored 32 papers that have together received 381 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (7 papers), Epigenetics and DNA Methylation (3 papers), DNA Repair Mechanisms (2 papers), Ubiquitin and proteasome pathways (2 papers), Ferroptosis and cancer prognosis (2 papers), Hormonal and reproductive studies (2 papers), Computational Drug Discovery Methods (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). The work is most often cited by research in Cancer Research (47 citations), Oncology (60 citations), Molecular Biology (143 citations), Biochemistry (12 citations) and Pulmonary and Respiratory Medicine (52 citations). Yipeng Xu has collaborated with scholars based in China, Germany and France. Frequent co-authors include Shaoxing Zhu, Zongping Wang, Cheng-Yi Liu, Mei Song, Michel Raymond, Xu Yang, Feng Cui, Mylène Weill, Zihao Chen and Maïté Marquine. Their work appears in journals such as Frontiers in Pharmacology, Medicine, Biomedical Reports, Tumor Biology and Synthetic and Systems Biotechnology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.